1. 2550 Phase Ib study of abiraterone acetate (AA) plus buparlisib (BKM120) or BEZ235 in patients (pts) with castration-resistant prostate cancer (CRPC). (September 2015) Authors: Chi, K.; Castellano, D.; De Bono, J.; Gravis, G.; Dirix, L.; Machiels, J.P.; Mita, A.; Mellado Gonzalez, B.; Massard, C.; Trandafir, L.; Dey, D.; Csonka, D.; Chakravartty, A.; Fizazi, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2554 Clinical outcome of initially metastatic hormone sensitive prostate cancer (HSPC) in real life population from a single center: Comparison with initially metastatic HSPC patients included in the GETUG-AFU 15 trial. (September 2015) Authors: Guerin, M.; Sfumato, P.; Boher, J.M.; Salem, N.; Dermeche, S.; Thomassin, J.; Fizazi, K.; Joly, F.; Oudard, S.; Habibian, M.; Culine, S.; Walz, J.; Gravis, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2560 Baseline serum clusterin level in patients with poor prognostic features was associated with response to custirsen treatment: Results from the phase 3 SYNERGY trial of docetaxel +/- custirsen. (September 2015) Authors: De Bono, J.; Higano, C.; Blumenstein, B.; Feyerabend, S.; Gravis, G.; Ferrero, J.M.; Jacobs, C.; Chi, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases. (December 2017) Authors: Loriot, Y.; Pagliaro, L.; Fléchon, A.; Mardiak, J.; Geoffrois, L.; Kerbrat, P.; Chevreau, C.; Delva, R.; Rolland, F.; Theodore, C.; Roubaud, G.; Gravis, G.; Eymard, J.C.; Malhaire, J.P.; Linassier, C.; Habibian, M.; Martin, A.L.; Journeau, F.; Reckova, M.; Logothetis, C. Journal: European journal of cancer Issue: Volume 87(2017) Page Start: 140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Q-TWiST analysis of patients with metastatic castrate naive prostate cancer treated by androgen deprivation therapy with or without docetaxel in the randomised phase III GETUG-AFU 15 trial. (October 2017) Authors: Marino, P.; Sfumato, P.; Joly, F.; Fizazi, K.; Oudard, S.; Culine, S.; Habibian, M.; Boher, J.-M.; Gravis, G. Journal: European journal of cancer Issue: Volume 84(2017) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗